Genomma Lab Internacional, S.A.B. de C.V.
GNMLF
$0.96
$0.010.82%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -33.24% | -50.35% | 11.39% | 710.04% | 60.63% |
| Total Depreciation and Amortization | 9.26% | 35.88% | -10.43% | 185.30% | 32.32% |
| Total Amortization of Deferred Charges | -- | -- | -- | -32.64% | -- |
| Total Other Non-Cash Items | -64.95% | -10.71% | -55.13% | -112.69% | 96.35% |
| Change in Net Operating Assets | -125.96% | 64.76% | 14.01% | 10.69% | 216.88% |
| Cash from Operations | -69.45% | 9.25% | 0.75% | 36.88% | 99.48% |
| Capital Expenditure | -222.25% | -375.12% | -91.67% | -126.22% | 26.40% |
| Sale of Property, Plant, and Equipment | -93.90% | -22.60% | -- | 16.81% | 5,621.05% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 91.86% | 73.92% | 54.91% | 143.03% | -619.26% |
| Cash from Investing | 69.10% | -14.45% | -124.54% | 91.52% | -1,337.56% |
| Total Debt Issued | -8.82% | 34.24% | 70.00% | -12.83% | 35.55% |
| Total Debt Repaid | 13.15% | -20.97% | 19.60% | 10.19% | -40.41% |
| Issuance of Common Stock | -- | -11.76% | -- | -5.77% | -- |
| Repurchase of Common Stock | -- | -- | -36.81% | 10.23% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -102.88% | 100.00% | 15.34% | 16.95% | 8.86% |
| Other Financing Activities | 18.02% | -5.24% | -14.16% | -18.28% | -1.53% |
| Cash from Financing | -47.85% | 141.31% | 107.54% | 20.34% | -7.87% |
| Foreign Exchange rate Adjustments | -252.42% | -395.64% | -27.16% | -80.31% | 178.98% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -140.83% | 468.23% | 67.51% | 925.38% | 42.47% |